Jump to content

OBI Pharma Granted FDA Orphan Drug Designation for the Treatment of Pancreatic Cancer for Its Antibody-Drug Conjugate (ADC) Targeted Cancer Therapy, OBI-999


In The News

Recommended Posts

Archived

This topic is now archived and is closed to further replies.



×
×
  • Create New...